Understanding first-line treatment patterns and survival outcomes across sociodemographic groups of women with metastatic triple-negative breast cancer in the United States: a real-world study
This study demonstrated generally similar treatment patterns and poor survival outcomes across sociodemographic groups, highlighting an unmet need for more efficacious treatments for all women with mTNBC.
Authors
- Yara George Abdou (ORCID: https://orcid.org/0000-0002-4827-8613)
- Laura M. Spring (ORCID: https://orcid.org/0000-0001-8904-3514)
- Cosmina S. Hogea (ORCID: https://orcid.org/0000-0002-0686-2395)
- K. Kalinsky
- Sara M. Tolaney (ORCID: https://orcid.org/0000-0002-5940-8671)
- N. Sjekloca
- Adina Estrin (ORCID: https://orcid.org/0000-0001-8866-2911)
- Chia‐Hsuan Lai
- M K Rehnquist
Institutions
- University of North Carolina at Chapel Hill (US)
- Harvard University (US)
- Emory University (US)
- Massachusetts General Hospital (US)
- Gilead Sciences (United Kingdom) (GB)
- Aetion (United States) (US)
- Dana-Farber Cancer Institute (US)
- Gilead Sciences (United States) (US)
Publication Details
- Journal
- ESMO Open
- Published
- 2025-10-01
- DOI
- https://doi.org/10.1016/j.esmoop.2025.105841
- Citations
- 2
- Primary Topic
- Cancer Treatment and Pharmacology
- Type
- article
- Field-Weighted Citation Impact
- 2.09